Anti-Cancer Drugs Journal Issues Research Articles in February 2022 Edition
January 17, 2022
January 17, 2022
LONDON, England, Jan. 17 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles, including the following topics, in its February 2022 edition:
Pre-Clinical Reports:
* Oxaliplatin facilitates tumor-infiltration of T cells and natural-kil . . .
Pre-Clinical Reports:
* Oxaliplatin facilitates tumor-infiltration of T cells and natural-kil . . .